CN Patent
CN116041347B — 非奈利酮中间体的制备方法
Assigned to Bozhiyan New Taizhou Pharmaceutical Technology Co ltd · Expires 2025-12-09 · 0y expired
What this patent protects
本发明公开了一种非奈利酮中间体3的制备方法,其包括以下步骤:有机溶剂中,将非奈利酮中间体2与D‑酒石酸二苯酯进行拆分反应,得到拆分盐,然后与碱进行酸碱反应,得到所述的非奈利酮中间体3。本发明的制备方法,反应步骤短、反应总收率高、操作简单安全、后处理步骤简单、制得的产品纯度高、生产成本低、适合于工业化生产。
USPTO Abstract
本发明公开了一种非奈利酮中间体3的制备方法,其包括以下步骤:有机溶剂中,将非奈利酮中间体2与D‑酒石酸二苯酯进行拆分反应,得到拆分盐,然后与碱进行酸碱反应,得到所述的非奈利酮中间体3。本发明的制备方法,反应步骤短、反应总收率高、操作简单安全、后处理步骤简单、制得的产品纯度高、生产成本低、适合于工业化生产。
Drugs covered by this patent
- Kerendia (FINERENONE) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.